Two Form 144 notices filed 2026-09-15 signal insider selling intent at Revolution Medicines. Margaret A. Horn (Officer) intends to sell 29,600 shares (~$4.74M) via RSU vesting. Mark A. Goldsmith (Director) intends to sell 80,000 shares (~$16.74M) from trusts. Combined ~$21.5M in proposed sales. This follows 8 insider sells totaling $4.3M in the past 30 days. The sales are RSU-vesting and trust-related, not open-market discretionary, but the dollar amounts are material relative to recent insider activity. Market cap is $44.0B, so the sales are small relative to company size. Impact: moderate negative tilt, score 4.
RVMD drugs
RVMD drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 16 $195.92entry
- T+1 · 2mo ago +0.52%α −0.61% · $196.94
- T+5 · 8w ago −2.64%α −5.21% · $190.74
- T+20 · 5w ago −3.82%α −7.00% · $188.44
- T+43 · todayOpen
- T+60 · in 23d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Form 144 notices filed 2026-09-15 signal insider selling intent at Revolution Medicines. Margaret A. Horn (Officer) intends to sell 29,600 shares (~$4.74M) via RSU vesting. Mark A. Goldsmith (Director) intends to sell 80,000 shares (~$16.74M) from trusts. Combined ~$21.5M in proposed sales. This follows 8 insider sells totaling $4.3M in the past 30 days. The sales are RSU-vesting and trust-related, not open-market discretionary, but the dollar amounts are material relative to recent insider activity. Market cap is $44.0B, so the sales are small relative to company size. Impact: moderate negative tilt, score 4.
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (RVMD), Batch item 1 | 0001294192-26-000005 |
| Document: 0001294192-26-000005-index.html | 0001246842-26-000006 |
| Document: 0001294192-26-000005.txt | 0001294192-26-000005 |
| 144 Filing (RVMD), Batch item 4 | 0001246842-26-000006 |
| Document: 0001246842-26-000006-index.html | 0001294192-26-000005 |
| Document: 0001246842-26-000006.txt | 0001294192-26-000005 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers